ClinicalTrials.Veeva
Menu

Find clinical trials for Diabetes in San Francisco, CA

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Type 2 Diabetes Mellitus
Diabetes Mellitus
Obesity
Type 1 Diabetes Mellitus
Overweight
Diabetic Foot
Foot Ulcer

Diabetes trials near San Francisco, CA, USA:

Sotagliflozin to Slow Kidney Function Decline in Persons With Type 1 Diabetes and Diabetic Kidney Disease (SUGARNSALT)

inhibitors (SGLT2i) - are now available for patients with type 2 diabetes. Whether these drugs have similar effects in patients with type 1 ...

Enrolling
Diabetic Nephropathies
Diabetes Mellitus Type 1
Drug: Placebo
Drug: Sotagliflozin

Phase 3

Alessandro Doria

Stanford, California, United States and 18 other locations

The purpose of this study is to assess the safety and pharmacokinetics (PK) of teplizumab in participants with Stage 2 type 1 diabetes who a...

Active, not recruiting
Diabetes Mellitus, Type 1
Biological: teplizumab

Phase 4

Sanofi
Sanofi

San Francisco, California, United States and 9 other locations

for youth 10 to \<18 years old with newly diagnosed stage 3 type 1 diabetes (T1D). The study will also evaluate the effect of an Afrezza plu...

Enrolling
Type 1 Diabetes Mellitus
Drug: Technosphere Insulin
Drug: Basal insulin

Phase 2

MannKind
MannKind

San Francisco, California, United States and 9 other locations

of the fully closed loop Omnipod M System in adults with type 2 diabetes using basal/bolus insulin therapy or basal-only insulin therapy, wi...

Enrolling
Type 2 Diabetes Mellitus
Device: Device: Omnipod M System with study CGM
Device: Standard Therapy plus study CGM
Insulet

Vallejo, California, United States and 14 other locations

OPL-0401-201 is a multicenter study to investigate the safety and efficacy of OPL-0401 in patients with diabetes mellitus (DM) with diabetic...

Active, not recruiting
Non-proliferative Diabetic Retinopathy
Proliferative Diabetic Retinopathy
Drug: Placebo
Drug: OPL-0401 Dose 1

Phase 2

Valo Health

Mountain View, California, United States and 24 other locations

This feasibility study is a prospective, single center, multi-arm study evaluating possible enhancements to the SteadiSet extended wear infusion set.

Active, not recruiting
Diabetes Mellitus, Type 1
Device: SteadiSet Infusion Set
Tandem Diabetes Care
Tandem Diabetes Care

Stanford, California, United States

This study is testing whether a new medication called CX11 works and is safe for participants with type 2 diabetes who have not reached good...

Enrolling
Type II Diabetes Mellitus
Other: Placebo
Drug: CX11

Phase 2

Corxel Pharmaceuticals

Walnut Creek, California, United States and 44 other locations

The main purpose of this study is to learn more about the safety and efficacy of investigational tirzepatide doses in participants with Type 2 diabetes...

Active, not recruiting
Type 2 Diabetes
Obesity
Drug: Tirzepatide
Drug: Placebo

Phase 2

Lilly
Lilly

Concord, California, United States and 40 other locations

Diabetic Retinopathy (DR) is a common eye condition caused by diabetes, where high blood sugar levels damage the blood vessels in t...

Enrolling
Diabetic Retinopathy
Drug: Topical Steroid
Drug: Artificial Tears

Phase 2, Phase 3

AbbVie
AbbVie

Mountain View, California, United States and 5 other locations

The objective of DIAGNODE-3 is to evaluate the efficacy and safety of three intranodal injections of 4 μg of Diamyd also known as retogatein compared...

Active, not recruiting
Type 1 Diabetes Mellitus
Biological: Recombinant human glutamic acid decarboxylase (rhGAD65) formulated in Alhydrogel®
Biological: Placebo

Phase 3

Diamyd Medical

Palo Alto, California, United States and 59 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems